Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Codex DNA, Inc. | 10%+ Owner | Common Stock | 469K | $1.32M | $2.83 | Jun 22, 2021 | By: Northpond Ventures II, LP |
Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 1M | Oct 15, 2024 | By Northpond Ventures II, LP | ||
Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 764K | Oct 15, 2024 | By Northpond Ventures III, LP | ||
Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 471K | Oct 15, 2024 | By Northpond Ventures, LP | ||
Camp4 Therapeutics Corp | 10%+ Owner | Series A Prime Preferred Stock | 0 | Oct 15, 2024 | By Northpond Ventures II, LP | ||
Camp4 Therapeutics Corp | 10%+ Owner | Series B Preferred Stock | 0 | Oct 15, 2024 | By Northpond Ventures, LP |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CAMP | Camp4 Therapeutics Corp | Oct 15, 2024 | 5 | $8.4M | 4 | Oct 17, 2024 | 10%+ Owner |
CAMP | Camp4 Therapeutics Corp | Oct 10, 2024 | 0 | $0 | 3 | Oct 10, 2024 | 10%+ Owner |
TBIO | Codex DNA, Inc. | Jun 22, 2021 | 0 | $0 | 3 | Jun 24, 2021 | 10%+ Owner |